Skip Navigation
Skip to contents

ACC : Acute and Critical Care


Author index

Page Path
HOME > Issue > Author index
Yong Jun Jeon 2 Articles
Risk factor, monitoring, and treatment for snakebite induced coagulopathy: a multicenter retrospective study
Yong Jun Jeon, Jong Wan Kim, SungGil Park, Dong Woo Shin
Acute Crit Care. 2020;35(1):56-56.   Published online February 29, 2020
Corrects: Acute Crit Care 2019;34(4):269
  • 3,328 View
  • 90 Download
Risk factor, monitoring, and treatment for snakebite induced coagulopathy: a multicenter retrospective study
Yong Jun Jeon, Jong Wan Kim, SungGil Park, Dong Woo Shin
Acute Crit Care. 2019;34(4):269-275.   Published online November 18, 2019
Correction in: Acute Crit Care 2020;35(1):56
  • 4,721 View
  • 155 Download
  • 6 Citations
AbstractAbstract PDF
Snakebite can cause various complications, including coagulopathy. The clinical features of snakebite-associated coagulopathy differ from those of disseminated intravascular coagulation (DIC) caused by other diseases and its treatment is controversial.
We retrospectively reviewed the medical records of patients hospitalized for snakebite between January 2006 and September 2018.
A total of 226 patients were hospitalized due to snakebite. Their median hospital stay was 4.0 days (interquartile range, 2.0 to 7.0 days). Five patients arrived at hospital with shock and one patient died. Twenty-one patients had overt DIC according to the International Society of Thrombosis and Hemostasis scoring system. Two patients developed major bleeding complications. Initial lower cholesterol level at presentation was associated with the development of overt DIC. International normalization ratio (INR) exceeding the laboratory’s measurement limit was recorded as late as 4 to 5 days after the bite. Higher antivenom doses (≥18,000 units) and transfusion of fresh frozen plasma (FFP) or cryoprecipitate did not affect prolonged INR duration or hospital stay in the overt DIC patients without bleeding.
Initial lower cholesterol level may be a risk factor for overt DIC following snakebite. Although patients lack apparent symptoms, the risk of coagulopathy should be assessed for at least 4 to 5 days following snakebite. Higher antivenom doses and transfusion of FFP or cryoprecipitate may be unbeneficial for coagulopathic patients without bleeding.


Citations to this article as recorded by  
  • A simple mortality risk prediction score for viper envenoming in India (VENOMS): A model development and validation study
    Maya Gopalakrishnan, Suman Saurabh, Pramod Sagar, Chanaveerappa Bammigatti, Tarun Kumar Dutta, Nicholas R. Casewell
    PLOS Neglected Tropical Diseases.2022; 16(2): e0010183.     CrossRef
  • Attempt for a Recombinant Thrombomodulin Alpha Treatment in a Rat Disseminated Intravascular Coagulation Model Using Yamakagashi (Rhabdophis tigrinus) Venom
    Akihiko Yamamoto, Takashi Ito, Toru Hifumi
    Toxins.2022; 14(5): 322.     CrossRef
  • Coagulopathy following Crotaliπae snakebites in northeast Florida
    Satish Maharaj, Karan Seegobin, Simone Chang
    Blood Coagulation & Fibrinolysis.2022; 33(4): 220.     CrossRef
  • Unmasking the ties of snake bite poisoning and COVID-19
    Anjuman Chander, Tanvir Samra, Sekar Loganathan, Varun Mahajan
    Ain-Shams Journal of Anesthesiology.2022;[Epub]     CrossRef
  • Venom induced consumption coagulopathy and performance of 20-min whole blood clotting test for its detection in viperid envenomation
    Bayye Rajkumar, Kolar Vishwanath Vinod, Rakhee Kar, Premkumar Ramasubramani
    Journal of the Royal College of Physicians of Edinburgh.2022; 52(3): 232.     CrossRef
  • The effect of myocardial injury on the clinical course of snake envenomation in South Korea
    J. M. Moon, Y. J. Koo, B. J. Chun, K. H. Park, Y. S. Cho, J. C. Kim, S. D. Lee, Y. R. Min, H. S. Park
    Clinical Toxicology.2021; 59(4): 286.     CrossRef

ACC : Acute and Critical Care